(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.
To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Morimoto Y et al. | Asymmetric total synthesis of highly symmetric squalene-derived cytotoxic polyethers. | 2002 | Chirality | pmid:12112332 |
Broeders NE et al. | Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort study. | 2011 | Clin J Am Soc Nephrol | pmid:21921153 |
Nestel PJ and Kudchodkar B | Plasma squalene as an index of cholesterol synthesis. | 1975 | Clin Sci Mol Med | pmid:1204294 |
Beran J et al. | A phase III, randomized, open-label study to assess the tolerability and immunogenicity of an H5N1 influenza vaccine administered to healthy adults with a 1-, 2-, 3-, or 6-week interval between first and second doses. | 2010 | Clin Ther | pmid:21316535 |
Messeri G et al. | Amniotic fluid squalene and gestational age. | 1982 | Clin. Chem. | pmid:7094305 |
Wysocki SJ et al. | Simultaneous assessment of fetal lung maturity and sebaceous gland function by gas chromatography. | 1984 | Clin. Chim. Acta | pmid:6705230 |
Yamanishi Y et al. | Serum squalene levels in hepatobiliary diseases. | 1978 | Clin. Chim. Acta | pmid:679482 |
Hallikainen M et al. | Postprandial behavior of plasma squalene and non-cholesterol sterols in men with varying cholesterol absorption. | 2006 | Clin. Chim. Acta | pmid:16814761 |
Senthilkumar S et al. | Effect of squalene on cyclophosphamide-induced toxicity. | 2006 | Clin. Chim. Acta | pmid:16150433 |
Simonen P et al. | Acute effects of weight reduction on cholesterol metabolism in obese type 2 diabetes. | 2002 | Clin. Chim. Acta | pmid:11750274 |
Ketomäki A et al. | Removal of intravenous Intralipid in patients with familial hypercholesterolemia during inhibition of cholesterol absorption and synthesis. | 2004 | Clin. Chim. Acta | pmid:15149875 |
Hirayama C et al. | Serum cholesterol and squalene in hepatocellular carcinoma. | 1979 | Clin. Chim. Acta | pmid:216506 |
Nikkilä K et al. | Liver transplantation modifies serum cholestanol, cholesterol precursor and plant sterol levels. | 1992 | Clin. Chim. Acta | pmid:1499139 |
Cho S et al. | High-dose squalene ingestion increases type I procollagen and decreases ultraviolet-induced DNA damage in human skin in vivo but is associated with transient adverse effects. | 2009 | Clin. Exp. Dermatol. | pmid:19522983 |
Milanetti F et al. | Safety and immunogenicity of co-administered MF59-adjuvanted 2009 pandemic and plain 2009-10 seasonal influenza vaccines in rheumatoid arthritis patients on biologicals. | 2014 | Clin. Exp. Immunol. | pmid:24666311 |
Holm BC et al. | Adjuvant oil induces waves of arthritogenic lymph node cells prior to arthritis onset. | 2004 | Clin. Exp. Immunol. | pmid:15196244 |
Holm BC et al. | The arthritogenic adjuvant squalene does not accumulate in joints, but gives rise to pathogenic cells in both draining and non-draining lymph nodes. | 2002 | Clin. Exp. Immunol. | pmid:11966758 |
Son J et al. | Immunogenicity of low-dose MF59-adjuvanted 2009 influenza A/H1N1 vaccine in dialysis patients. | 2013 | Clin. Exp. Nephrol. | pmid:22990301 |
Hoschler K et al. | Administration of AS03B-adjuvanted A(H1N1)pdm09 vaccine in children aged <3 years enhances antibody response to H3 and B viruses following a single dose of trivalent vaccine one year later. | 2014 | Clin. Infect. Dis. | pmid:24149079 |
Manuel O et al. | Humoral response to the influenza A H1N1/09 monovalent AS03-adjuvanted vaccine in immunocompromised patients. | 2011 | Clin. Infect. Dis. | pmid:21288852 |
Atmar RL et al. | Safety and immunogenicity of nonadjuvanted and MF59-adjuvanted influenza A/H9N2 vaccine preparations. | 2006 | Clin. Infect. Dis. | pmid:17029131 |
Cunningham CK et al. | Safety of 2 recombinant human immunodeficiency virus type 1 (HIV-1) envelope vaccines in neonates born to HIV-1-infected women. | 2001 | Clin. Infect. Dis. | pmid:11229849 |
Bate J et al. | Immunogenicity of pandemic (H1N1) 2009 vaccine in children with cancer in the United Kingdom. | 2010 | Clin. Infect. Dis. | pmid:21067352 |
Kawakami T et al. | Evaluation of heterotopic bone formation induced by squalane and bone morphogenetic protein composite. | 1997 | Clin. Orthop. Relat. Res. | pmid:9137198 |
Kudchodkar BJ et al. | Mechanisms of hypolipidemic action of nicotinic acid. | 1978 | Clin. Pharmacol. Ther. | pmid:688728 |
O'Hagan DT et al. | MF59 is a safe and potent vaccine adjuvant for flu vaccines in humans: what did we learn during its development? | 2007 | Clin. Pharmacol. Ther. | pmid:17971820 |
Rajaratnam RA et al. | Impaired postprandial clearance of squalene and apolipoprotein B-48 in post-menopausal women with coronary artery disease. | 1999 | Clin. Sci. | pmid:10409473 |
Berglund J et al. | Safety, immunogenicity, and antibody persistence following an investigational Streptococcus pneumoniae and Haemophilus influenzae triple-protein vaccine in a phase 1 randomized controlled study in healthy adults. | 2014 | Clin. Vaccine Immunol. | pmid:24173029 |
Fragapane E et al. | A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. | 2010 | Clin. Vaccine Immunol. | pmid:20810680 |
Del Giudice G et al. | Vaccines with the MF59 adjuvant do not stimulate antibody responses against squalene. | 2006 | Clin. Vaccine Immunol. | pmid:16960112 |
Cheong HJ et al. | Immunogenicity and safety of the influenza A/H1N1 2009 inactivated split-virus vaccine in young and older adults: MF59-adjuvanted vaccine versus nonadjuvanted vaccine. | 2011 | Clin. Vaccine Immunol. | pmid:21715575 |
Viganò A et al. | Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. | 2011 | Clin. Vaccine Immunol. | pmid:21795458 |
Song JY et al. | Comparison of the long-term immunogenicity of two pandemic influenza A/H1N1 2009 vaccines, the MF59-adjuvanted and unadjuvanted vaccines, in adults. | 2012 | Clin. Vaccine Immunol. | pmid:22379067 |
Huijskens E et al. | Immunogenicity, boostability, and sustainability of the immune response after vaccination against Influenza A virus (H1N1) 2009 in a healthy population. | 2011 | Clin. Vaccine Immunol. | pmid:21795459 |
Fox CB et al. | Effects on immunogenicity by formulations of emulsion-based adjuvants for malaria vaccines. | 2012 | Clin. Vaccine Immunol. | pmid:22896687 |
Durando P et al. | Safety and immunogenicity of two influenza virus subunit vaccines, with or without MF59 adjuvant, administered to human immunodeficiency virus type 1-seropositive and -seronegative adults. | 2008 | Clin. Vaccine Immunol. | pmid:18003811 |
Bihari I et al. | Assessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects. | 2012 | Clin. Vaccine Immunol. | pmid:23081815 |
Lopez P et al. | Combined administration of MF59-adjuvanted A/H5N1 prepandemic and seasonal influenza vaccines: long-term antibody persistence and robust booster responses 1 year after a one-dose priming schedule. | 2013 | Clin. Vaccine Immunol. | pmid:23536690 |
Fox CB et al. | Monitoring the effects of component structure and source on formulation stability and adjuvant activity of oil-in-water emulsions. | 2008 | Colloids Surf B Biointerfaces | pmid:18440205 |
Lewis DJ et al. | Rapid and frequent induction of protective immunity exceeding UK recommendations for healthcare settings by MF59-adjuvated hepatitis B vaccine. | 2003 | Commun Dis Public Health | pmid:15067859 |
Frayha GJ | A study of the synthesis and absorption of cholesterol in hydatid cysts (Echinococcus granulosus). | 1968 | Comp. Biochem. Physiol. | pmid:5710286 |
VAN DEN OORD A | THE ABSENCE OF CHOLESTEROL SYNTHESIS IN THE CRAB, CANCER PAGURUS L. | 1964 | Comp. Biochem. Physiol. | pmid:14246359 |
Blondin GA et al. | The biosynthesis of squalene and sterols in fish. | 1966 | Comp. Biochem. Physiol. | pmid:4380202 |
Frayha GJ and Fairbairn D | Lipid metabolism in helminth parasites--VI. Synthesis of 2-cis,6-trans farnesol by Hymenolepis diminuta (Cestoda). | 1969 | Comp. Biochem. Physiol. | pmid:4306773 |
Silva CJ et al. | Biosynthetic studies of marine lipids. 35. The demonstration of de novo sterol biosynthesis in sponges using radiolabeled isoprenoid precursors. | 1991 | Comp. Biochem. Physiol., B | pmid:1790671 |
Teshima SI and Kanazawa A | Biosynthesis of sterols in a starfish, Laiaster leachii. | 1975 | Comp. Biochem. Physiol., B | pmid:1183195 |
Phleger CF et al. | Pressure effect on squalene-2,3-oxide cyclization in fish. | 1973 | Comp. Biochem. Physiol., B | pmid:4719990 |
Anderson DG | Gorgosterol biosynthesis: localization of squalene formation in the zooxanthellar component of various gorgonians. | 1985 | Comp. Biochem. Physiol., B | pmid:2861942 |
Wells JW | Steroids in the pineal gland of the domestic fowl (Gallus domesticus): cholesterol and its biosynthesis. | 1971 | Comp. Biochem. Physiol., B | pmid:5133342 |
Silva CJ and Djerassi C | Biosynthetic studies of marine lipids 36. The origin of common sterol side chains in eleven sponges using [3-3H]-squalene. | 1992 Jan-Feb | Comp. Biochem. Physiol., B | pmid:1499273 |